| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 1,052 | 1,160 | 1,206 | 1,116 | 1,028 | 1,108 | 1,083 | 1,018 | 920 | 928 | 1,077 | 1,042 | 1,010 | 1,015 | 1,132 | 1,048 | 880 | 760 | 705 | 807 | 720 | 2,077 | 730 | 865 | 640 | 861 | 866 | 856 | 669 | 652 | 736 | 701 | 710 | 658 | 777 | 709 | 754 | 769 | 818 | 729 |
| Expenses | 943 | 973 | 1,031 | 1,001 | 945 | 1,016 | 964 | 995 | 1,028 | 1,309 | 1,001 | 959 | 1,024 | 1,003 | 1,058 | 1,064 | 827 | 726 | 670 | 656 | 674 | 1,298 | 697 | 706 | 698 | 739 | 765 | 742 | 871 | 611 | 831 | 657 | 771 | 642 | 681 | 664 | 803 | 648 | 699 | 593 |
| EBITDA | 109 | 187 | 175 | 116 | 83 | 92 | 119 | 23 | -108 | -381 | 76 | 84 | -15 | 12 | 74 | -16 | 53 | 34 | 35 | 151 | 47 | 779 | 33 | 159 | -58 | 122 | 101 | 114 | -202 | 41 | -95 | 44 | -61 | 16 | 96 | 45 | -49 | 121 | 119 | 136 |
| Operating Profit % | 13 % | 15 % | 16 % | 7 % | 6 % | 7 % | 9 % | 0 % | -19 % | -47 % | 2 % | 5 % | -1 % | 0 % | 6 % | -2 % | 4 % | -0 % | 2 % | 12 % | 2 % | -117 % | 2 % | 8 % | -10 % | 14 % | 11 % | 13 % | -33 % | -3 % | -22 % | 6 % | -14 % | 0 % | 10 % | 5 % | -15 % | 12 % | 14 % | 18 % |
| Depreciation | 34 | 35 | 35 | 36 | 37 | 36 | 37 | 38 | 37 | 37 | 36 | 38 | 38 | 39 | 40 | 41 | 45 | 55 | 53 | 56 | 61 | 56 | 57 | 68 | 65 | 64 | 61 | 62 | 59 | 64 | 65 | 66 | 56 | 55 | 55 | 55 | 58 | 54 | 55 | 55 |
| Interest | 14 | 24 | 30 | 32 | 43 | 49 | 56 | 61 | 59 | 61 | 68 | 62 | 65 | 73 | 65 | 64 | 64 | 71 | 65 | 79 | 61 | 74 | 61 | 60 | 55 | 64 | 69 | 80 | 86 | 73 | 70 | 83 | 76 | 79 | 76 | 77 | 73 | 73 | 73 | 60 |
| Profit Before Tax | 60 | 128 | 110 | 48 | 4 | 7 | 26 | -76 | -204 | -480 | -28 | -16 | -118 | -100 | -32 | -121 | -55 | -92 | -82 | 16 | -75 | 649 | -85 | 31 | -178 | -6 | -29 | -28 | -347 | -96 | -230 | -105 | -193 | -118 | -35 | -87 | -180 | -6 | -9 | 21 |
| Tax | 27 | 30 | 12 | -22 | 17 | -9 | 1 | -16 | 3 | -17 | -19 | 27 | 35 | -5 | -1 | -44 | -41 | -55 | 12 | -3 | -144 | -111 | -88 | -1 | -71 | 1 | -66 | -30 | -36 | -21 | -23 | -3 | 44 | 18 | 38 | -1 | -3 | 10 | 7 | 1 |
| Net Profit | 33 | 98 | 98 | 69 | -13 | 17 | 25 | -60 | -207 | -463 | -9 | -43 | -153 | -95 | -31 | -77 | -14 | -37 | -94 | 19 | 69 | 760 | 3 | 32 | -107 | -7 | 37 | 2 | -311 | -75 | -207 | -102 | -237 | -136 | -73 | -86 | -177 | -16 | -16 | 20 |
| EPS in ₹ | 3.10 | 8.36 | 8.37 | 6.52 | -0.49 | 1.44 | 2.25 | -4.88 | -15.81 | -37.06 | -0.80 | -3.69 | -13.97 | -7.79 | -2.06 | -6.42 | -2.62 | -4.06 | -7.42 | 0.87 | 4.36 | 68.64 | 0.32 | 1.38 | -8.38 | -1.15 | 2.79 | -0.61 | -21.20 | -4.64 | -13.15 | -6.62 | -14.37 | -9.28 | -5.37 | -5.75 | -11.64 | -0.95 | -1.47 | 0.91 |
Wockhardt
1,294.80
-15.30
(-1.17%)
Market Cap
21,038.63 Cr
EPS
-32.05
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
1,679.90
52 Week Low
490.15
PB Ratio
4.84
Debt to Equity
0.68
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,836.60 | #1 4,40,661.86 | 37.20 | #1 49,887.20 | 12.06 | #1 9,648 | 13.77 | 62.24 | |
6,124.50 | 1,62,586.23 | 78.35 | 8,184.00 | 0.89 | 1,600 | #1 64.53 | 60.86 | |
1,542.90 | 1,24,606.91 | 24.70 | 26,520.70 | 14.17 | 4,155 | 47.38 | 57.59 | |
3,285.20 | 1,11,186.10 | 59.18 | 10,785.70 | 11.59 | 1,656 | 13.54 | 54.31 | |
2,415.40 | 99,654.22 | 48.14 | 10,615.60 | 19.57 | 1,942 | -16.38 | 46.37 | |
1,171.30 | 97,739.76 | #1 18.38 | 28,905.40 | 12.36 | 5,578 | 1.69 | 51.52 | |
2,085.30 | 95,202.48 | 32.75 | 20,141.50 | #1 19.94 | 1,936 | 38.82 | 54.25 | |
892.50 | 89,806.38 | 19.65 | 19,831.50 | 13.82 | 3,831 | 29.92 | 53.95 | |
1,242.00 | 72,135.56 | 19.97 | 29,559.20 | 17.55 | 3,169 | -10.04 | 59.05 | |
30,725.00 | 65,288.48 | 48.97 | 6,097.20 | 10.80 | 1,201 | 16.01 | 55.94 |
Growth Rate
Revenue Growth
3.89 %
Net Income Growth
-23.99 %
Cash Flow Change
43.14 %
ROE
-24.00 %
ROCE
-68.73 %
EBITDA Margin (Avg.)
-47.39 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 6,939 | 8,121 | 9,022 | 8,162 | 7,844 | 8,179 | 7,774 | 8,243 | 7,683 | 7,649 |
| Fixed Assets | 2,123 | 2,809 | 2,773 | 2,888 | 3,058 | 3,502 | 3,343 | 3,462 | 3,042 | 2,881 |
| Current Assets | 3,522 | 3,952 | 4,535 | 3,380 | 2,815 | 2,430 | 2,425 | 2,589 | 2,208 | 2,184 |
| Capital Work in Progress | 1,007 | 1,036 | 1,244 | 1,433 | 1,446 | 1,585 | 1,379 | 1,342 | 1,539 | 1,722 |
| Investments | 339 | 0 | 563 | 214 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 3,470 | 4,276 | 4,443 | 3,628 | 3,341 | 3,092 | 3,052 | 3,439 | 3,102 | 3,046 |
| Total Liabilities | 6,939 | 8,121 | 9,022 | 8,162 | 7,844 | 8,179 | 7,774 | 8,243 | 7,683 | 7,649 |
| Current Liabilities | 1,773 | 1,842 | 1,979 | 2,692 | 2,864 | 3,497 | 3,121 | 3,207 | 3,435 | 2,791 |
| Non Current Liabilities | 1,307 | 2,039 | 3,324 | 2,272 | 1,976 | 1,624 | 894 | 834 | 586 | 1,196 |
| Total Equity | 3,859 | 4,241 | 3,719 | 3,198 | 3,005 | 3,058 | 3,759 | 4,202 | 3,662 | 3,662 |
| Reserve & Surplus | 3,362 | 3,720 | 3,281 | 2,797 | 2,620 | 2,616 | 3,321 | 3,777 | 3,282 | 3,282 |
| Share Capital | 354 | 55 | 55 | 55 | 55 | 55 | 55 | 72 | 72 | 77 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 57 | 46 | 301 | -66 | -500 | -178 | 13 | 138 | -280 | 415 |
| Investing Activities | -222 | -106 | -684 | 635 | 93 | -147 | 1,471 | -204 | -118 | -138 |
| Operating Activities | 355 | -42 | -270 | 68 | 183 | 649 | -287 | 413 | 153 | 219 |
| Financing Activities | -76 | 193 | 1,255 | -770 | -777 | -680 | -1,171 | -71 | -315 | 334 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Nov 2024 | Dec 2024 | Mar 2025 |
| Promoter | 72.12 % | 69.68 % | 68.04 % | 67.13 % | 67.13 % | 65.75 % | 63.83 % | 60.36 % | 59.31 % | 58.40 % | 55.14 % | 54.93 % | 51.60 % | 51.99 % | 51.99 % | 49.09 % | 49.09 % | 49.09 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 3.02 % | 0.00 % | 5.49 % | 5.93 % | 6.70 % | 6.62 % | 6.54 % | 6.81 % |
| DIIs | 0.02 % | 0.02 % | 0.02 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.23 % | 0.22 % | 0.19 % | 0.22 % | 0.10 % | 4.83 % | 4.45 % | 5.09 % | 9.88 % | 9.82 % | 10.59 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % |
| Public / Retail | 21.41 % | 23.02 % | 25.24 % | 25.99 % | 24.56 % | 25.97 % | 27.42 % | 30.26 % | 31.45 % | 32.19 % | 32.89 % | 32.94 % | 29.94 % | 30.18 % | 29.02 % | 27.45 % | 27.49 % | 26.69 % |
| Others | 6.46 % | 7.27 % | 6.69 % | 6.85 % | 8.28 % | 8.26 % | 8.72 % | 9.15 % | 9.02 % | 9.21 % | 8.72 % | 12.03 % | 8.13 % | 7.43 % | 7.19 % | 6.95 % | 7.04 % | 6.80 % |
| No of Share Holders | 0 | 0 | 1,25,128 | 1,44,845 | 1,61,625 | 1,65,270 | 1,66,122 | 1,80,170 | 1,80,630 | 1,78,915 | 1,72,989 | 1,61,813 | 1,46,376 | 1,40,391 | 1,38,142 | 1,43,876 | 1,42,710 | 1,41,799 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 1.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 07 Feb 2025 |  Quarterly Result Announcement | NA | 07 Feb 2025 | 1,558.55 | 1,651.10 |
| 13 Nov 2024 | Quarterly Result Announcement | NA | 13 Nov 2024 | 1,206.50 | 1,180.80 |
| 28 Jun 2024 |  Annual General Meeting | NA | 28 Jun 2024 | 514.90 | 653.75 |
| 09 Mar 2022 |  Rights | 3:10 | 08 Mar 2022 | 311.72 | 308.20 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Apr 11, 2025
Apr 11, 2025Intimation For Incorporation Of A Step-Down Subsidiary Company
Apr 08, 2025
Apr 08, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 01, 2025
Apr 01, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 14, 2025
Feb 14, 2025Integrated Filing (Financial)Feb 07, 2025
Feb 07, 2025Statement On Deviation Or Variation Of Funds Raised Through Qualified Institutions Placements For The Quarter Ended 31St December 2024Feb 07, 2025
Feb 07, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 07, 2025
Feb 07, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 07, 2025
Feb 07, 2025Board Meeting Outcome for Outcome Of The Board MeetingFeb 07, 2025
Feb 07, 2025Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited
Feb 03, 2025
Feb 03, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 31, 2025
Jan 31, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Jan 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 13, 2025
Jan 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 02, 2025
Jan 02, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 16, 2024
Dec 16, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 27, 2024
Nov 27, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 21, 2024
Nov 21, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 18, 2024
Nov 18, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 14, 2024
Nov 14, 2024Statement On Deviation Or Variation Of Funds Raised Through Qualified Institutions Placement For The Quarter Ended 30Th June, 2024 Confirming That There Has Been No Deviation In The Utilization Of Issue Proceeds.Nov 13, 2024
Nov 13, 2024Please Find Enclosed Herewith The Monitoring Agency Report Towards Utilization Of Proceeds Of Qualified Institutions Placement ('QIP') For The Quarter Ended September 30, 2024, Issued By CRISIL Ratings Limited.Nov 13, 2024
Nov 13, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 13, 2024
Nov 13, 2024Unaudited Financial Results For Quarter And Half Year Ended September 30, 2024Nov 13, 2024
Nov 13, 2024Announcement under Regulation 30 (LODR)-AllotmentNov 11, 2024
Nov 11, 2024Board Meeting Outcome for Outcome Of The Meeting Of The Capital Raising CommitteeNov 11, 2024
Nov 11, 2024Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt LimitedNov 08, 2024
Nov 08, 2024Board Meeting Outcome for Outcome Of The Meeting Of The Capital Raising Committee For Qualified Institutions Placement Of Equity Shares Of Face Value Of ? 5 Each (The 'Equity Shares') To Qualified Institutional Buyers ('QIB').Nov 06, 2024
Nov 06, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 25, 2024
Oct 25, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 24, 2024
Oct 24, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 21, 2024
Oct 21, 2024Announcement under Regulation 30 (LODR)-Investor PresentationOct 21, 2024
Oct 21, 2024Reply To BSE''s Email Dated 16Th October, 2024 Relating To Volume MovementOct 16, 2024
Oct 16, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 16, 2024
Oct 16, 2024Clarification sought from Wockhardt LtdOct 16, 2024
Oct 16, 2024Disclosure under Regulation 30A of LODROct 16, 2024
Oct 16, 2024Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 15, 2024
Oct 15, 2024Disclosure under Regulation 30A of LODROct 11, 2024
Oct 11, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 09, 2024
Oct 09, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 07, 2024
Oct 07, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 03, 2024
Oct 03, 2024Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2024
Sep 30, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 30, 2024
Sep 30, 2024Closure of Trading WindowSep 26, 2024
Sep 26, 2024Press Release -'Dr. Habil Khorakiwala Bestowed Lifetime Achievement Award By Integrated Health And Wellbeing Council In Dubai'.Sep 23, 2024
Sep 23, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 19, 2024
Sep 19, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 19, 2024
Sep 19, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 16, 2024
Sep 16, 2024Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015Sep 14, 2024
Sep 14, 2024Technical Indicators
RSI(14)
Neutral 42.89
ATR(14)
Less Volatile 71.14
STOCH(9,6)
Oversold 19.84
STOCH RSI(14)
Neutral 21.15
MACD(12,26)
Bearish -10.64
ADX(14)
Weak Trend 16.75
UO(9)
Bearish 36.59
ROC(12)
Downtrend And Accelerating -7.67
WillR(14)
Neutral -76.27
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
